To further demonstrate the effect of eEF-2K suppression on the sensitivity of mTOR inhibitor against breast cancer cell, we compared the cell viability in response to combined treatment of mTOR inhibitor with eEF-2K siRNA or Beclin 1 siRNA. Here, BECN1 is linked to breast carcinoma.